AAAAAA
Results:
1-13
|
Results: 13
Authors:
Dezutter, NA
Landman, WJM
Jager, PL
de Groot, TJ
Dupont, PJ
Tooten, PCJ
Zekarias, B
Gruys, E
Verbruggen, AM
Citation: Na. Dezutter et al., Evaluation of Tc-99m-MAMA-chrysamine G as an in vivo probe for amyloidosis, AMYLOID, 8(3), 2001, pp. 202-214
Authors:
Luurtsema, G
Jager, PL
Piers, A
de Hooge, MN
Citation: G. Luurtsema et al., An automated synthesis module for preparation of L-3-[I-123]iodo-alpha-methyl tyrosine, APPL RAD IS, 55(6), 2001, pp. 783-788
Authors:
Siebelink, HMJ
Blanksma, PK
Crijns, HJGM
Bax, JJ
van Boven, AJ
Kingma, T
Piers, DA
Pruim, J
Jager, PL
Vaalburg, W
van der Wall, EE
Citation: Hmj. Siebelink et al., Patient management guided by viability imaging - Reply, J AM COL C, 38(4), 2001, pp. 1272-1273
Authors:
Siebelink, HMJ
Blanksma, PK
Crijns, HJGM
Bax, JJ
van Boven, AJ
Kingma, T
Piers, DA
Pruim, J
Jager, PL
Vaalburg, W
van der Wall, EE
Citation: Hmj. Siebelink et al., No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management - A prospective, randomized comparison of patients with suspicion of jeopardized myocardium, J AM COL C, 37(1), 2001, pp. 81-88
Authors:
Jager, PL
Groen, HJM
van der Leest, A
van Putten, JWG
Pieterman, RM
de Vries, EGE
Piers, DA
Citation: Pl. Jager et al., L-3-[I-123]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer:Preliminary observations, J NUCL MED, 42(4), 2001, pp. 579-585
Authors:
Jager, PL
Vaalburg, W
Pruim, J
de Vries, EGE
Langen, KJ
Piers, DA
Citation: Pl. Jager et al., Radiolabeled amino acids: Basic aspects and clinical applications in oncology, J NUCL MED, 42(3), 2001, pp. 432-445
Authors:
Jager, PL
De Vries, EGE
Piers, DA
Timmer-Bosscha, H
Citation: Pl. Jager et al., Uptake mechanisms of L-3-[I-125]iodo-alpha-methyl-tyrosine in a human small-cell lung cancer cell line: comparison with L-1-[C-14]tyrosine, NUCL MED C, 22(1), 2001, pp. 87-96
Authors:
Jager, PL
Kooistra, A
Piers, DA
Citation: Pl. Jager et al., Treatment with radioactive (89)strontium for patients with bone metastasesfrom prostate cancer, BJU INT, 86(8), 2000, pp. 929-934
Authors:
Jager, PL
Plaat, BEC
de Vries, EGE
Molenaar, WM
Vaalburg, W
Piers, DA
Hoekstra, HJ
Citation: Pl. Jager et al., Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: Comparison with proliferative and mitotic activity, cellularity, and vascularity, CLIN CANC R, 6(6), 2000, pp. 2252-2259
Authors:
van Tol, KM
Hew, JM
Jager, PL
Vermey, A
Dullaart, RPF
Links, TP
Citation: Km. Van Tol et al., Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma, CLIN ENDOCR, 52(5), 2000, pp. 653-659
Authors:
Jager, PL
Meijer, WG
Kema, IP
Willemse, PHB
Piers, DA
de Vries, EGE
Citation: Pl. Jager et al., L-3-[I-123]iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: Correlation with biochemical activity and comparison with [In-111-DTPA-D-Phe(1)]-octreotide imaging, J NUCL MED, 41(11), 2000, pp. 1793-1800
Authors:
van Tol, KM
Jager, PL
Dullaart, RPF
Links, TP
Citation: Km. Van Tol et al., Follow-up in patients with differentiated thyroid carcinoma with positive F-18-fluoro-2-deoxy-D-glucose-positron emission tomography results, elevated thyroglobulin levels, and negative high-dose I-131 posttreatment whole body scans, J CLIN END, 85(5), 2000, pp. 2082-2083
Authors:
Jager, PL
Hoekstra, HJ
Leeuw, JA
van der Graaf, WTA
de Vries, EGE
Piers, DA
Citation: Pl. Jager et al., Routine bone scintigraphy in primary staging of soft tissue sarcoma - Is it worthwhile?, CANCER, 89(8), 2000, pp. 1726-1731
Risultati:
1-13
|